Drug Patents owned by King Pharms
1. Drug name - LEVOXYL
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7101569 | KING PHARMS | Methods of administering levothyroxine pharmaceutical compositions |
Oct, 2023
(11 months from now) | |
Drugs and Companies using LEVOTHYROXINE SODIUM ingredient
Treatment: Method of use of administering levothyroxine
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 0.025MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.05MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.075MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.088MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.1MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.112MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.125MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.137MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.15MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.175MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.2MG **See current Annual Edition, 1.8 Description of Special Situations, Levothyroxine Sodium | TABLET;ORAL | Prescription |
| 0.3MG | TABLET;ORAL | Discontinued |
2. Drug name - SKELAXIN
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7122566 | KING PHARMS | Metaxalone products, method of manufacture, and method of use |
Feb, 2026
(3 years from now) | |
Drugs and Companies using METAXALONE ingredient
Treatment: Treatment of musculoskeletal conditions
Dosage: TABLET;ORAL
More Information on Dosage
| Strength | Dosage | Availability |
|---|---|---|
| 400MG | TABLET;ORAL | Discontinued |
| 800MG | TABLET;ORAL | Prescription |
availability in other generic markets.
Click on the highlighted region to filter.